---
title: "role_of_induction_chemotherapy-of-hnscc"
date: "2024-09-28"
tags:
  - building
---

> [!NOTE]
> ðŸŒ± created from: [[head_and_neck_squamous_cell_cancer]]

# role_of_induction_chemotherapy-of-hnscc

- Rationale:
  - â†“ sxs a/w 1Â° tumor size, organ preservation, â†“ risk of distant mets;
  - controversial as
    - â†‘ duration of tx
    - potential â†‘ tox risk
    - no trials have yet shown OS advantage of induction + CRT vs. CRT alone
- If induction chosen, docetaxel, CIS, 5-FU standard
  - ([[eortc_24971.md|EORTC 24971]]/[[tax_323.md|TAX 323]] NEJM 2007;357:1695)
  - TPF
  - [[rtog_91-11.md|RTOG 91-11]]

> å¤§éƒ¨åˆ†åœ¨ induction åŠ å…¥ CCRT éƒ½æ²’æœ‰ OS çš„å„ªå‹¢ï¼Œå”¯ä¸€æœ‰çš„ trial æœ‰é¡¯è‘—ï¼Œcontrol
> arm çš„ locoregional control éƒ½æ¯”è¼ƒå·®
